Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ATAD5 |
| Upstream (Parents) |
|---|
| (<<) EFHD1 → ATAD5 |
| (<<) ZNF711 → ATAD5 |
| (<<) C19orf66 → ATAD5 |
| (<<) SHC2 → ATAD5 |
| (<<) SIGIRR → ATAD5 |
| Downstream (Children) |
|---|
| ATAD5 → ERC2 (>>) |
| ATAD5 → LOC100287076 (>>) |
| ATAD5 → ADAM30 (>>) |
| ATAD5 → CENPF (>>) |
| ATAD5 → GPR50 (>>) |
| ATAD5 → MED24 (>>) |
| ATAD5 → GNPTAB (>>) |
| ATAD5 → TMEM40 (>>) |
| ATAD5 → CGB8///CGB7///CGB5///CGB (>>) |
| ATAD5 → C1QL1 (>>) |
| ATAD5 → MRPS18C (>>) |
| ATAD5 → ZNF205 (>>) |
| ATAD5 → LOC100131510 (>>) |
| ATAD5 → RPLP2P1 (>>) |
